FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients
WASHINGTON, D.C. — The U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate …
Read More